Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy
Shijie Cao(University of Washington), Jeffrey A. Hubbell(University of Chicago)
Cited by 12
Related Papers
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
|Nature Biotechnology|2007|1.3k
Materials engineering for immunomodulation
|Nature|2009|549
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
|Science Advances|2023|27
Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics
|Nature Biomedical Engineering|2025|3